Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00112112 · ClinicalTrials.gov registry record · Phase 1
Safety Study to Evaluate FluMist in Immunocompromised Children
A Phase 1 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00112112 is a Phase 1 study that has completed, run by MedImmune. The registered enrollment target is 20 participants.
The verdict
NCT00112112, a Phase 1 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The main purpose of this study is to get information about the safety of a flu vaccine spray, called FluMist, in children with cancer. The study is also being done to find out how much and how long the vaccine spray can be found in the nose.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL FluMist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-08-01 |
| Est. Completion | 2008-05-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00112112
The ClinicalTrials.gov registry entry for NCT00112112 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00112112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00112112 about?
NCT00112112 is a clinical study titled "Safety Study to Evaluate FluMist in Immunocompromised Children". The main purpose of this study is to get information about the safety of a flu vaccine spray, called FluMist, in children with cancer. The study is also being done to find out how much and how long the vaccine spray can be found in the nose.
What is the current status of trial NCT00112112?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2005-08-01. Estimated completion is 2008-05-01.
What interventions are being tested in trial NCT00112112?
The interventions under investigation include: Placebo (BIOLOGICAL), FluMist (BIOLOGICAL).
Who is sponsoring clinical trial NCT00112112?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.